June 26, 2020 / 6:19 PM / 16 days ago

BRIEF-Pfenex Announces Positive European CHMP Opinion For Livogiva & New Partnership In Latin America

June 26 (Reuters) - Pfenex Inc:

* PFENEX ANNOUNCES POSITIVE EUROPEAN CHMP OPINION FOR PF708 (EU BRAND NAME: LIVOGIVA™) AND NEW PARTNERSHIP IN LATIN AMERICA, AND PROVIDES CRM197 BUSINESS UPDATE

* PFENEX - CO’S COMMERCIAL PARTNER ADALVO ENTERED INTO COMMERCIALIZATION AGREEMENT IN LATIN AMERICA FOR PF708

* PFENEX INC - THERAMEX RECEIVED A POSITIVE OPINION FOR PF708 (BRANDED IN EUROPE AS LIVOGIVA) FROM CHMP Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below